{
    "2019-01-25": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen",
                "features": {
                    "keywords": [
                        "CVS",
                        "migraine drugs",
                        "Teva",
                        "Lilly",
                        "Amgen"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Merck KGaA Gives Vertex Rights to Two Gene-Editing Compounds",
                "features": {
                    "keywords": [
                        "Merck KGaA",
                        "Vertex",
                        "Gene-Editing",
                        "Compounds"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-28",
                "original_text": "Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "JNJ",
                        "BMY",
                        "Q4 Earnings",
                        "Study Failures",
                        "LLY",
                        "ABBV"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}